Inhibition of Chronic Ulcerative Colitis-associated Adenocarcinoma Development in Mice by VSL#3

VSL#3 Probiotic Upregulates Intestinal Mucosal Alkaline Sphingomyelinase and Reduces Inflammation

(2016) Isaac Soo et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Predictive utility of cyclo-oxygenase-2 expression by colon and rectal cancer

(2014) Kristel C. Lobo Prabhu et al.   AMERICAN JOURNAL OF SURGERY

The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead

(2014) Aleksandar D. Kostic et al.   GASTROENTEROLOGY

Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis

(2014) Y Wang et al.   Mucosal Immunology

Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis

(2014) Marco Scarpa   WORLD JOURNAL OF GASTROENTEROLOGY

Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease

(2013) Laurent Beaugerie et al.   GASTROENTEROLOGY

Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohnʼs Disease, and Pouchitis

(2013) Jun Shen et al.   INFLAMMATORY BOWEL DISEASES

Feeding with olive oil attenuates inflammation in dextran sulfate sodium-induced colitis in rat

(2013) Toru Takashima et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Role of cyclooxygenase-2 in gastric cancer development and progression

(2013) Jian Cheng   WORLD JOURNAL OF GASTROENTEROLOGY

VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer

(2013) Janelle C. Arthur et al.   Scientific Reports

Interleukin-10 and Interleukin-10–Receptor Defects in Inflammatory Bowel Disease

(2012) Neil Shah et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Probiotics, their health benefits and applications for developing healthier foods: a review

(2012) Ravinder Nagpal et al.   FEMS MICROBIOLOGY LETTERS

VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis

(2012) Cong Dai et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Immunoregulatory Mechanisms Underlying Prevention of Colitis-Associated Colorectal Cancer by Probiotic Bacteria

(2012) Josep Bassaganya-Riera et al.   PLoS One

Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer

(2011) Caroline B. Appleyard et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Gut microbiota and probiotics in colon tumorigenesis

(2011) Yuanmin Zhu et al.   CANCER LETTERS

Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis

(2011) Pieter Friederich et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Probiotics Modulate Intestinal Expression of Nuclear Receptor and Provide Counter-Regulatory Signals to Inflammation-Driven Adipose Tissue Activation

(2011) Andrea Mencarelli et al.   PLoS One

Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis

(2010) Siew C. Ng et al.   INFLAMMATORY BOWEL DISEASES

Role of different inflammatory and tumor biomarkers in the development of ulcerative colitis-associated carcinogenesis

(2010) E. Talero et al.   INFLAMMATORY BOWEL DISEASES

Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis

(2010) Joshua M. Uronis et al.   INFLAMMATORY BOWEL DISEASES

Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis

(2009) Rudolf Mennigen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer

(2009) Sergei Grivennikov et al.   CANCER CELL

The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity

(2009) P. Vavassori et al.   JOURNAL OF IMMUNOLOGY